Application Note: WB: 1:2000. IHC-P: 1:50-1:100. FACS: 1:10-1:50. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 49
Form: Liquid
Buffer (with preservative): PBS, 0.09% Sodium Azide.
Concentration: Batch dependent (Please refer to the vial label for the specific concentration.)
Background: Sulfonation, an important step in the metabolism of many drugs, xenobiotics, hormones, and neurotransmitters, is catalyzed by sulfotransferases. This gene encodes galactosylceramide sulfotransferase, which catalyzes the sulfation of membrane glycolipids including the final step in the synthesis of sulfatide, a major lipid component of the myelin sheath. This gene exhibits elevated expression in ovarian epithelial carcinoma and the encoded enzyme exhibits elevated activity in renal cell carcinoma. Mutations in this gene may be associated with reduced insulin resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Uniprot ID: Q99999
Antigen Species: Human
Immunogen: KLH conjugated synthetic peptide between 88-116 amino acids from the Central region of human GAL3ST1.
Purification: Purified by protein A column followed by antigen-affinity chromatography.
Conjugation: Unconjugated
Full Name: galactose-3-O-sulfotransferase 1
Deutsch
English
